Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT06768918 (AMBeR eRehab) for Cancer Rehabilitation, Cancer is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Digitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries (AMBeR eRehab) 300 Telehealth International
Clinical Trial NCT06768918 (AMBeR eRehab) is an interventional study for Cancer Rehabilitation, Cancer that is recruiting. It started on 3 October 2024 with plans to enroll 300 participants. Led by Zealand University Hospital, it is expected to complete by 31 December 2026. The latest data from ClinicalTrials.gov was last updated on 12 March 2026.
Brief Summary
Background
With increasing cancer incidence and advanced cancer treatment, the growing population of cancer survivors increases the demand on health resources worldwide. Over the last 20 years, physical rehabilitation has reached recognition as an essential component of cancer care due its effect on physical function, side effects of treatment, and quality of life. However, highly specialized health care can result ...
Show MoreDetailed Description
Detailed Description
Introduction
Increasing survival rates in cancer patients has put an increasing focus on physical rehabilitation in survivorship. Physical rehabilitation plays an important role in the cancer care continuum by improving Quality of Life, functional ability and participation in everyday life. Often, however, patients may be unable to participate due to barriers related to resources, social suppor...
Show MoreOfficial Title
Digitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries
Conditions
Cancer RehabilitationCancerPublications
Scientific articles and research papers published about this clinical trial:Other Study IDs
- AMBeR eRehab
- p-2024-17503
NCT ID Number
Start Date (Actual)
2024-10-03
Last Update Posted
2026-03-12
Completion Date (Estimated)
2026-12-31
Enrollment (Estimated)
300
Study Type
Interventional
PHASE
N/A
Status
Recruiting
Keywords
Remote physical rehabilitation
cancer rehabilitation
e-health
implementation
feasibility
acceptability
exercise
physiotherapy
home-based
oncology
usability
cancer rehabilitation
e-health
implementation
feasibility
acceptability
exercise
physiotherapy
home-based
oncology
usability
Primary Purpose
Supportive Care
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
ExperimentalDigital physical rehabilitation Feasibility testing the implementation of digitally delivered physical rehabilitation a) during systemic anticancer treatment and b) after completion of systemic anticancer treatment | Remote physical rehabilitation In this multisite international study, we feasibility test implementation of 4 different digital solutions for delivering interactive physical rehabilitation during or after systemic anticancer treatment. The contents of the intervention follows international recommendations for exercise during or after treatment for cancer. |
Primary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Patient's and therapist perspectives on determinants | 2 Qualitative analyses using online Group Concept Mapping will be performed. One with 5-10 patients in their final phase of the rehabilitation program (minimum 1 participant each country), and one with 5-10 therapists/health professionals (minimum one each country). One -two promps phrased to create responses from informants about what the determinants are for engaging in digital e-rehabilitation, will be specified by the project group in collaboration. The process will further follow 5 pre-described steps of online activities, utilizing the software "GroupwisdomTM", The steps are as follows: Step 1) Brainstorming the prompt(s) Steps 2 and 3) Sorting, labelling and rating Step 4) Generating a cluster rating map Step 5) Validation of the cluster rating map We will perform the process separately for patients and therapists. | Patients: between 4 and 12 weeks of intervention participation. Therapists: between 5 patient treatments completed and end of study (on average 1 year). |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
- Diagnosed with cancer (IDC: C00* - C97*)
- Feasibility study 1 (early rehab): Participants should receive any systemic chemo/immunotherapy preferably (but not necessarily) with a duration of 8 weeks or more. Recruitment should be at earliest convenience preferably (but not necessarily) within 4 weeks of treatment initiation.
- Feasibility study 2 (rehab@home): Participants should preferably have completed chemotherapy/immunotherapy no more than 6 months ago but may be receiving long-standing maintenance and life-prolonging chemo-/immunotherapy.
- Cognitively unable to give consent to, or participate in, a digital rehabilitation programme as judged by project team staff.
Zealand University Hospital- 🎓Klaipėda Univers...
Study Responsible Party
Susanne Dalton, Principal Investigator, Professor, Zealand University Hospital
Study Central Contact
Contact: Gunn Ammitzbøll, PhD, + 45 22 46 27 33, [email protected]
Contact: susanne O Dalton, PhD, + 45 35 25 76 18, [email protected]
5 Study Locations in 5 Countries
Zealand Unievrsity Hospital, Næstved, 4700, Denmark
Gunn Ammitzbøll, PhD, Contact, +4522462733, [email protected]
Susanne Oksbjerg Dalton, PhD, Contact, +4535257618, [email protected]
Gunn Ammitzbøll, PhD, Sub-Investigator
Recruiting
University Medical Center Rostock, Rostock, 18057, Germany
Dr. Sabine Felser, PhD, Contact, 0381 494 7421, [email protected]
Kathrin Thiele, MSc, Contact, [email protected]
Sabine Felser, PhD, Principal Investigator
Recruiting
Klaipeda University, Klaipėda, LT-92294, Lithuania
Aelita Bredelyte, PhD, Contact, +370 46 39 89 06, [email protected]
Gunn Ammitzbøll, PhD, Contact, +4522462733, [email protected]
Aelita Bredelyte, PhD, Principal Investigator
Recruiting
Medical University of Gdansk, Gdansk, 80-210, Poland
Dariusz Szplit, PhD, Contact, +48 58 349 11 11, [email protected]
Gunn Ammitzbøll, PhD, Contact, +4522462733, [email protected]
Dariusz Szplit, PhD, Principal Investigator
Recruiting
Ängelholm Hospital, Ängelholm, 26281, Sweden
Hanna Lotzke, PhD, Contact, +46 431 810 00, [email protected]
Patrik Göransson, MSc, Contact, [email protected]
Hanna Lotzke, PhD, Principal Investigator
Recruiting